House Oversight Hearing Slams Inflation Reduction Act, But Ignores China’s Role

House Oversight Hearing Slams Inflation Reduction Act, But Ignores China’s Role

Archive, China, commentary, Commentary Featured, CPA News, Featured Home Page, Industrial Policy, Manufacturing, Newsroom, Renewable Energy, Supply Chain, Trade and Tariffs

In a House Oversight subcommittee hearing on Feb. 26, the Inflation Reduction Act (IRA) was hit with the usual swipes from detractors, with some calling it the “green scam”, but China’s solar company benefits were never mentioned.

China Drug Exports to U.S. Rise as America Reaches a Crossroads in Its Own Supply Shortfalls

China Drug Exports to U.S. Rise as America Reaches a Crossroads in Its Own Supply Shortfalls

Archive, China, commentary, Commentary Featured, CPA News, Featured Home Page, Guest Opinion & Press Releases, Healthcare, Industrial Policy, Manufacturing, Newsroom, Trade and Tariffs

In 2024, China and India accounted for 57.6% of total U.S. pharmaceutical imports by weight, highlighting the potential risks associated with such reliance. Growing U.S. dependence on China and India for widely-used generic pharmaceutical products creates serious risks to national security and patient safety when drugs are in short supply, or ineffective.